Hanan Medicare

Hanan Medicare is a privately owned Malaysian pharmaceutical company founded in 2014 and headquartered in Rawang, Selangor. It supplies oral solid dosage medicines, medical devices and hospital sundries to public and private healthcare providers, and through its GMP-certified associate GoodScience (acquired in 2021) it has been expanding since 2025 into higher-value biosimilar manufacturing, including insulin.

  • Biotechnology
  • Medtech
  • Pharmaceuticals
  • Healthcare & Life Sciences

1

Round

1

Industry

3

Tags

Oct 13, 2026

Latest raise

Funding activity · 1 round

Raise timeline

  1. Oct 13, 2026

    Undisclosed

    • VentureTECH Sdn Bhd

    Article coming soon.

Pricing

Research Hanan Medicare — then scale the playbook

Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.

Enterprise

Custom pricing for unlimited scale. Let's talk.

Contact sales

Growth plan

For individuals and small teams getting started with AI buyer intelligence.

$149

/month

Features

  • Access to core AI adoption signals
  • 3–5 curated slices per week
  • 30–60 companies / week
  • AI Adoption Score
  • Deal-ready insights (why + pitch angle)
  • Basic filters (recency, slice, score)
  • CSV export
Most popular

Pro plan

For outbound teams and agencies that need more coverage and faster signal cadence.

$249

/month

Features

  • Everything in Growth, plus:
  • Full access to all slices
  • 60–120 companies / week
  • Higher-frequency signal updates
  • Priority / early signals (before Growth)
  • Advanced filters (industry, size, use case)
  • Deeper company insights
  • Faster export + bulk workflows

Act on this raise

See if Hanan Medicare is moving on AI

Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.

© 2026 VeilStrat. All rights reserved.All systems operational